News | Women's Health | June 06, 2017

Carolina Breast Imaging Specialists Adopts iCAD’s Advanced AI Technology for Digital Breast 3-D Tomo

iCAD’s PowerLook Tomo Detection deep learning solution helps radiologists identify breast cancer more efficiently

concurrent-read cancer detection solution for digital breast tomosynthesis

Carolina Breast Imaging Specialists of Greenville, North Carolina today announced it is the first U.S. site to begin using iCAD’s advanced artificial intelligence technology, PowerLook Tomo Detection, in conjunction with GE Healthcare’s tomosynthesis platform. PowerLook Tomo Detection is a first-of-its-kind, concurrent-read cancer detection solution for digital breast tomosynthesis (DBT) and is engineered to make it possible for radiologists to detect breast cancer more efficiently. 

Medical facilities worldwide are increasingly adopting DBT technology for screening and diagnostic mammography. Tomosynthesis produces hundreds of images compared to 2-D full field digital mammography which typically produces four images. With DBT, radiologists may have to spend significantly more time to review and interpret each exam. The PowerLook Tomo Detection deep learning algorithm automatically analyzes each slice in the tomosynthesis data set, supporting radiologists in identifying suspicious areas with greater speed and precision. Suspicious areas identified by PowerLook Tomo Detection are blended by GE Healthcare’s Seno Iris workstation into the 2-D synthetic image to provide radiologists with a single enhanced image, known as the Enhanced V-Preview image.

“More and more medical facilities are recognizing the benefits of tomosynthesis. It provides a more comprehensive view of each patient’s breast tissue compared to traditional 2-D digital mammography, but the larger data sets produced by DBT can be challenging for radiologists,” said Bruce Schroeder, M.D., Medical Director, Carolina Breast Imaging Specialists. “The Enhanced V-Preview image created by iCAD’s PowerLook Tomo Detection solution and GE Healthcare’s Seno Iris workstation allow radiologists to detect breast cancer in patients more efficiently without compromising clinical performance.”

In a U.S. clinical study conducted in 2016, radiologists were able to significantly reduce review time when reading 3-D tomosynthesis exams with PowerLook Tomo Detection. The study included 20 radiologists reading 240 tomosynthesis cases both with and without the PowerLook Tomo Detection technology. Reading time was reduced by up to 37 percent with an average reduction of 29 percent when using PowerLook Tomo Detection, with no statistically significant impact on sensitivity, specificity or recall rate. PowerLook Tomo Detection received FDA approval in March 2017 and is CE Marked in the European Union and licensed by Health Canada.

“We are excited to be the first facility in the US to offer this innovative solution,” continued Schroeder. “In using PowerLook Tomo Detection we have already seen the benefits for radiologists where we can now review the expansive tomosynthesis image sets more effectively. This allows us to spend our time analyzing abnormalities and consulting with our patients.”

In addition to Carolina Breast Imaging Specialists, iCAD expects multiple other facilities in the US to adopt PowerLook Tomo Detection in the coming months.

For more information: www.CBISpecialists.com

 

Related Content

Cianna Medical featured its wire-free marker system on the exhibit floor of the breast imaging symposium in Hollywood, Fla.

Cianna Medical featured its wire-free marker system on the exhibit floor of the breast imaging symposium in Hollywood, Fla.

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr
Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.
GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...
HHS Extends Comment Period for Proposed Electronic Health Information Interoperability Rules
News | Electronic Medical Records (EMR) | April 19, 2019
The U.S. Department of Health and Human Services (HHS) is extending the public comment period by 30 days for two...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care
News | Artificial Intelligence | April 18, 2019
Atrium Health patients will now be able to use Amazon’s electronic voice system Alexa to not only locate the nearest...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...